October 1st marked the formal implementation of a new American foreign aid architecture that NPR described as ushering in “a new era in US foreign aid.” Under the America First framework, countries receiving US development assistance — including healthcare and HIV/AIDS funding — must now sign a Memorandum of Understanding committing to a set of conditions. These include support for US foreign-policy positions, anti-corruption pledges, and what the administration calls “self-reliance” benchmarks that define an exit date from US assistance. The shift affects billions of dollars of annual aid across sub-Saharan Africa, Southeast Asia, and Latin America. Simultaneously, the Guardian reported that the State Department’s flagship human rights fund has been redirected toward grants including support for anti-communism programmes, a group advocating white Afrikaner rights in South Africa, and campaigns targeting Brazil’s supreme court. The combination of the MOU requirement and the ideological reorientation of human rights spending represents the most significant restructuring of American development diplomacy since the George W. Bush administration created PEPFAR in 2003.
The received wisdom
The development-policy community’s response has been alarm bordering on panic. PEPFAR and USAID programmes are credited — with considerable empirical justification — with dramatic reductions in HIV transmission rates, maternal mortality, and child malnutrition across dozens of countries. The conditionality framework, in this reading, will chill recipient governments’ willingness to accept US funding for fear of the political strings attached; drive some of them toward Chinese Belt and Road alternatives with no human rights conditions of any kind; and create a bureaucratic nightmare of reporting requirements that consumes the management capacity of health ministries that have little to spare. The Afrikaner-rights grant, in particular, has provoked bewildered outrage from career diplomats who see it as an explicit signal that human rights funding is now a vehicle for domestic American culture-war grievances rather than universal standards. This reading is not paranoid. There are enough specifics in the Guardian’s reporting to take seriously.
A different read
Before accepting the consensus view wholesale, it is worth being honest about what the old foreign aid system actually looked like from the inside.
The traditional US aid model — large institutional grants disbursed through USAID contractors and international NGOs, with accountability measured largely by process compliance rather than outcome — had problems that its defenders reliably refuse to acknowledge. NPR noted that the MOU framework has been “praised for promoting self-reliance” by some development economists who argue that the existing aid architecture creates dependency, undermines local government capacity, and channels resources through Western implementing partners who take significant overhead while delivering results that would not survive rigorous impact evaluation. This critique is not new. William Easterly made it exhaustively in The White Man’s Burden. Dambisa Moyo made a sharper version in Dead Aid. The evidence that large-scale, unconditional US government aid consistently builds the state capacity of recipient countries is, at best, mixed.
The self-reliance framework — requiring recipient governments to demonstrate progress toward funding their own health systems — is, in principle, not an unreasonable long-term objective. No serious development economist believes that perpetual external dependency on American funding for HIV prevention or childhood vaccination is a desirable end state. The question is whether the conditionality is genuinely designed to build that capacity, or whether it is designed to give Washington political leverage and provide a justification for eventual disengagement from commitments that the administration finds ideologically inconvenient or fiscally burdensome.
The ideological reorientation of the human rights fund is where the principled self-reliance argument runs into a wall. There is no coherent development or human rights theory under which an anti-communism fund in Europe, a white Afrikaner advocacy group, and a campaign against an independent judiciary in Brazil advance the conditions for sustainable development in the countries that receive mainstream US aid. These grants are not about building capacity; they are about rewarding political allies. If the administration is serious about principled conditionality — about making aid contingent on genuine anti-corruption progress and fiscal accountability — it should be able to explain why those criteria lead to funding Afrikaner rights groups. The silence on that question is revealing.
The historical stakes are high. PEPFAR has probably saved more lives per dollar than any US government programme in the post-Cold War period. The institutional relationships it built — between American public health agencies and African health ministries — represent decades of investment that cannot be reconstituted quickly if they are disrupted. An administration that genuinely cared about value for money and strategic return would proceed with extreme caution. What we are seeing instead looks more like ideological renovation of an institution the administration never trusted, using principled language to legitimate an outcome that has little to do with principles.
What to watch
Watch the Congressional response: PEPFAR has historically had genuine bipartisan support, and there are Republican senators whose states have significant evangelical constituencies with strong commitments to global health. If they push back on the conditionality framework, the administration may have to modify its approach. Watch how recipient governments respond to the MOU requirement: early refusals will tell us which countries are close enough to Chinese alternatives to risk antagonising Washington. Watch whether any of the new “human rights” grants survive legal challenge — the Afrikaner advocacy funding, in particular, may run into statutory requirements for grants from the human rights fund. And watch for any disruption to PEPFAR antiretroviral supply chains: in countries with high HIV prevalence, a six-week gap in drug delivery can be catastrophic.
--- J